<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">J Enzyme Inhib Med Chem</span><span class="iso-abbrev" title="iso-abbrev">J Enzyme Inhib Med Chem</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">Journal of Enzyme Inhibition and Medicinal Chemistry</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">1475-6366</span><span class="issn-epub" tagx="issn" title="issn-epub">1475-6374</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">Taylor &amp;amp; Francis</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/6896510">6896510</a></span><span class="pmid" title="pmid"> pmid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/31790606">31790606</a></span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1080/14756366.2019.1695792">10.1080/14756366.2019.1695792</a></span><span class="publisher-id" title="publisher-id">1695792</span><div class="unknown" title="article-version" tag="article-version">
Version of Record</div> <div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Rapid Communication</span>: <span class="subject" title="subject">Short Communication</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Evaluation of the paraoxonase-1 kinetic parameters of the lactonase activity by nonlinear fit of progress curves</div> <div class="alt-title" title="alt-title">
M. GoliÄ�nik and A. Bavec</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">GoliÄ�nik</span><span class="given-names" tagx="given-names" title="given-names">Marko</span></span><a href="#AF0001" /><a href="#AN0001" /></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bavec</span><span class="given-names" tagx="given-names" title="given-names">AljoÅ¡a</span></span><a href="#AF0001" /></span><span class="citation_author_institution" id="AF0001">[], <span class="institution" title="institution">Institute of Biochemistry, Faculty of Medicine, University of Ljubljana</span><span class="city" tagx="city" title="city">Ljubljana</span><span class="country" tagx="country" title="country">Slovenia</span></span></div> <div class="author-notes" title="author-notes"> <div class="corresp" title="corresp">
CONTACT Marko GoliÄ�nik <span class="email" tagx="email" title="email">marko.golicnik@mf.uni-lj.si</span><span class="institution" title="institution">Institute of Biochemistry, Faculty of Medicine, University of Ljubljana</span>, <span class="addr-line" title="addr-line">Vrazov trg 2</span>, <span class="city" tagx="city" title="city">Ljubljana</span>, <span class="postal-code" tagx="postal-code" title="postal-code">SI-1000</span>, <span class="country" tagx="country" title="country">Slovenia</span></div> </div><span class="pub-date-" title="pub-date-">: <span>2019-12-12</span></span><span class="pub-date-" title="pub-date-">: <span>2020</span></span><span class="volume" tagx="volume" title="volume">35</span><span class="issue" tagx="issue" title="issue">1</span><span class="fpage" tagx="fpage" title="fpage">261</span><span class="lpage" tagx="lpage" title="lpage">264</span><div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder">The Author(s)</span>, <span class="copyright-year" tagx="copyright-year" title="copyright-year">2019</span></span><span class="license" title="license"><span class="license-p" title="license-p">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<a href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</span></span></div><a class="self-uri" href="IENZ_35_1695792.pdf" title="self-uri">IENZ_35_1695792.pdf</a><div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <div class="title" tagx="title" title="title">
Abstract</div> <p>Although paraoxonase-1 (PON1) activity has been demonstrated to be a reliable biomarker of various diseases, clinical studies have been based only on relative comparison of specific enzyme activities, which capture differences mainly due to (usually unknown) PON1 concentration. Hence, the aim of this report is to present for the first time the simple evaluation method for determining autonomous kinetic parameter of PON1 that could be also associated with polymorphic forms and diseases; i.e. the Michaelis constant which is enzyme concentration independent quantity. This alternative approach significantly reduces the number of experiments needed, and it yields the results with great accuracy.</p> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Keywords</div> <div class="kwd" title="kwd">
Paraoxonase-1</div> <div class="kwd" title="kwd">
progressâ€"curve analysis</div> <div class="kwd" title="kwd">
nonlinear regression</div> <div class="kwd" title="kwd">
Lambert W function</div> </div> <div class="counts" title="counts"><span class="fig-count" title="fig-count">fig-count: </span><span class="table-count" title="table-count">table-count: </span><span class="page-count" title="page-count">page-count: </span><span class="word-count" title="word-count">word-count: </span></div> </div> </div> <div class="body" title="body"> <div class="intro" title="intro"> <div class="title" tagx="title" title="title">
Introduction</div> <p>Paraoxonase-1 (PON1) is a key Ca<sup>2+</sup>-dependent enzyme of liver-derived high-density lipoproteins (HDLs), which is linked to various pathophysiological disorders<a href="#CIT0001"><sup>1</sup></a>. Although the â€œphysiologicalâ€� substrates of PON1 appear to be lactones, PON1 has a large number of promiscuous activities towards organophosphate triesters, arylesters, thiolactones and cyclic carbamates<a href="#CIT0002"><sup>2</sup></a>. Thus, PON1-status can be determined by measuring enzyme activity levels with different substrates, and the latter can vary by over 10-fold between individuals with various PON1 genetic polymorphisms and pathological conditions<a href="#CIT0003"><sup>3</sup></a><sup>,</sup><a href="#CIT0004"><sup>4</sup></a>.</p> <p>The most convenient method for determining PON1-status and functional phenotype is based on 2-dimensional enzyme activity plot that displays rates of diazoxonase versus paraoxonase activity<a href="#CIT0005"><sup>5</sup></a><sup>,</sup><a href="#CIT0006"><sup>6</sup></a>. As this 2-substrate assay/plot technique involves the use of two highly toxic organophosphates, identification and characterisation of non-toxic discriminatory substrates for determination of PON1 activity still excites an interest among clinical researchers<a href="#CIT0007"><sup>7</sup></a>. Although current assays may provide substantial diagnostic â€œPON1 statusâ€� values, they are constrained only to the specific enzyme activity measurements which are unavoidably affected by (unknown) PON1 concentration and its affinity to a substrate. Even though if one PON1 alloform has a lower limiting rate <i>V</i><sub>max</sub>, but it has higher affinity (i.e. lower Michaelis constant <i>K</i><sub>m</sub>) for a particular substrate, then the catalytic efficiency (<i>V</i><sub>max</sub>/<i>K</i><sub>m</sub>) and consequently specific enzyme activity measurements of both PON1 alloforms can show nearly the same values. Further, another enzyme can form ternary complex with HDL and PON1; i.e. myeloperoxidase (MPO) which produces highly reactive oxidant hypochlorous acid (HOCl). MPO oxidises PON1 on tyrosine 71, a residue found that is critical for HDL binding which impairs catalytic abilities of PON1<a href="#CIT0008"><sup>8</sup></a>; i.e. substrate affinity to the enzyme active site and its turnover number. Although the latter cannot be determined when active enzyme concentration is unknown, the concentration independent <i>K</i><sub>m</sub> value can be more informative and consistent with true PON1 status. Thus, only an evaluation of complete set of PON1 kinetic parameters can provide predictive and conclusive evidence-based use of it as biomarker in health and disease.</p> </div> <div class="materials" title="materials"> <div class="title" tagx="title" title="title">
Materials and methods</div> <div class="studydesign" title="sec"> <div class="title" tagx="title" title="title">
Study design</div> <p>As our study was designed only for the development of simple and quick methodology for determination of PON1 kinetic characteristics, we selected leftover routine blood samples of six healthy blood-donors. Since the biological material used in this report were obtained from leftover routine specimens, and the samples were not used for any other particular study, informed consent from volunteers and ethical approval was unnecessary because the samples were no longer traceable.</p> </div> <div class="methods" title="sec"> <div class="title" tagx="title" title="title">
Methods</div> <p>Blood samples were collected in heparin containing tubes, and the cells were removed by centrifugation for 10â€‰min at 2000<b>Ã—</b><i>g</i>. Plasma samples were afterward stored in microtubes at 4â€‰Â°C. Lactonase hydrolytic activities of PON1 with dihydrocoumarin (Î"Îµ<sub>270</sub> = 1295â€‰M<sup>âˆ’1</sup>Â cm<sup>âˆ’1</sup>) were measured spectrophotometrically at 270â€‰nm<sup>2</sup> within 4â€‰h after the blood sample collection. In an assay the cuvette contained 100â€‰Î¼M substrate in 50â€‰mM Tris/HCl (pHÂ 8, 1â€‰mM CaCl<sub>2</sub>, and 1% of methanol) in a total volume of 2â€‰ml. The reaction was initiated by the addition of 20â€‰Î¼L of plasma, and full progress curve runs were carried out in less than 2â€‰min; i.e. unless the entire substrate was converted to product (<a href="#F0001">Figure 1)</a>. The measurements for each sample were carried in duplicate or triplicate.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 1.</span></a></div>   <p>Fit of kinetic progress curve data for each sample. Symbols represent absorbance readings at the given reaction time. Only one progress curve per sample and only half of the data points per progress curve are shown, for clarity. Smooth lines represent least-square model curves generated by fit of the theoretical equation <a href="#M0002">Equation (2)</a> with the parameter values obtained by modified model (GraphPad, Lambert W) shown in <a href="#t0001">Table 1</a>.</p>   </div> </div> <div class="dataanalysis" title="sec"> <div class="title" tagx="title" title="title">
Data analysis</div> <p>Progress curve experimental data were analysed by nonlinear regression fitting programme Dynafit using either numerical integration of differential equations that describe simple Michaelisâ€"Menten reaction model Eâ€‰+â€‰S â‡† ES â†’ Eâ€‰+â€‰P or newly described algebraic solution for the Michaelisâ€"Menten equation, which includes the Lambert <i>W</i>(<i>x</i>) function<a href="#CIT0009"><sup>9</sup></a><sup>,</sup><a href="#CIT0010"><sup>10</sup></a>: </p><div class="disp-formula" title="disp-formula"><span class="label" tagx="label" title="label">(1)</span><div class="alternatives" title="alternatives"> <div class="graphic" position="float" orientation="portrait" /><div class="math_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="msub_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
[</div> <div class="mi_UNKNOWN">
P</div> <div class="mo_UNKNOWN">
]</div> </div> <div class="mi_UNKNOWN">
t</div> </div> <div class="mo_UNKNOWN">
=</div> <div class="msub_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
[</div> <div class="mi_UNKNOWN">
S</div> <div class="mo_UNKNOWN">
]</div> </div> <div class="mn_UNKNOWN">
0</div> </div> <div class="mo_UNKNOWN">
âˆ’</div> <div class="msub_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
K</div> </div> <div class="mi_UNKNOWN">
m</div> </div> <div class="mo_UNKNOWN">
â‹…</div> <div class="msub_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
W</div> </div> <div class="mn_UNKNOWN">
0</div> </div> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
{</div> <div class="mrow_UNKNOWN"> <div class="mfrac_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="msub_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
[</div> <div class="mi_UNKNOWN">
S</div> <div class="mo_UNKNOWN">
]</div> </div> <div class="mn_UNKNOWN">
0</div> </div> </div> <div class="mrow_UNKNOWN"> <div class="msub_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
K</div> </div> <div class="mi_UNKNOWN">
m</div> </div> </div> </div> <div class="mo_UNKNOWN">
â‹…</div> <div class="mo_UNKNOWN">
â€‰</div> <div class="mtext_UNKNOWN">
exp</div> <div class="mo_UNKNOWN">
â€‰</div> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
(</div> <div class="mrow_UNKNOWN"> <div class="mfrac_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="msub_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
[</div> <div class="mi_UNKNOWN">
S</div> <div class="mo_UNKNOWN">
]</div> </div> <div class="mn_UNKNOWN">
0</div> </div> <div class="mo_UNKNOWN">
âˆ’</div> <div class="msub_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
V</div> </div> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
max</div> </div> </div> <div class="mo_UNKNOWN">
â‹…</div> <div class="mi_UNKNOWN">
t</div> </div> <div class="mrow_UNKNOWN"> <div class="msub_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
K</div> </div> <div class="mi_UNKNOWN">
m</div> </div> </div> </div> </div> <div class="mo_UNKNOWN">
)</div> </div> </div> <div class="mo_UNKNOWN">
}</div> </div> </div></div></div> </div> <p /> <p><i>V</i><sub>max</sub> and <i>K</i><sub>m</sub> in <a href="#M0001">Equation (1)</a> represent the limiting velocity and Michaelis constant, respectively. Finally, the approximation to the Lambert W function in <a href="#M0001">Equation (1)</a> for the product accumulation was also implemented into the GraphPad Prism (GraphPad Software, San Diego, California, USA) software package as a user-defined built-in explicit model equation for calculating model curves<a href="#CIT0011"><sup>11</sup></a>: </p><div class="disp-formula" title="disp-formula"><span class="label" tagx="label" title="label">(2)</span><div class="alternatives" title="alternatives"> <div class="graphic" position="float" orientation="portrait" /><div class="math_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="msub_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
[</div> <div class="mi_UNKNOWN">
P</div> <div class="mo_UNKNOWN">
]</div> </div> <div class="mi_UNKNOWN">
t</div> </div> <div class="mo_UNKNOWN">
=</div> <div class="msub_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
[</div> <div class="mi_UNKNOWN">
S</div> <div class="mo_UNKNOWN">
]</div> </div> <div class="mn_UNKNOWN">
0</div> </div> <div class="mo_UNKNOWN">
âˆ’</div> <div class="msub_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
K</div> </div> <div class="mi_UNKNOWN">
m</div> </div> <div class="mo_UNKNOWN">
â‹…</div> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
(</div> <div class="mrow_UNKNOWN"> <div class="mn_UNKNOWN">
1.45869</div> <div class="mo_UNKNOWN">
â‹…</div> <div class="mo_UNKNOWN">
â€‰</div> <div class="mtext_UNKNOWN">
ln</div> <div class="mo_UNKNOWN">
â€‰</div> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
(</div> <div class="mrow_UNKNOWN"> <div class="mn_UNKNOWN">
1.2</div> <div class="mo_UNKNOWN">
â‹…</div> <div class="mfrac_UNKNOWN"> <div class="mi_UNKNOWN">
x</div> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
â€‰</div> <div class="mtext_UNKNOWN">
ln</div> <div class="mo_UNKNOWN">
â€‰</div> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
(</div> <div class="mrow_UNKNOWN"> <div class="mn_UNKNOWN">
2.4</div> <div class="mo_UNKNOWN">
â‹…</div> <div class="mfrac_UNKNOWN"> <div class="mi_UNKNOWN">
x</div> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
â€‰</div> <div class="mtext_UNKNOWN">
ln</div> <div class="mo_UNKNOWN">
â€‰</div> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
(</div> <div class="mrow_UNKNOWN"> <div class="mn_UNKNOWN">
1</div> <div class="mo_UNKNOWN">
+</div> <div class="mn_UNKNOWN">
2.4</div> <div class="mo_UNKNOWN">
â‹…</div> <div class="mi_UNKNOWN">
x</div> </div> <div class="mo_UNKNOWN">
)</div> </div> </div> </div> </div> <div class="mo_UNKNOWN">
)</div> </div> </div> </div> </div> <div class="mo_UNKNOWN">
)</div> </div> <div class="mo_UNKNOWN">
âˆ’</div> <div class="mn_UNKNOWN">
0.45869</div> <div class="mo_UNKNOWN">
â‹…</div> <div class="mo_UNKNOWN">
â€‰</div> <div class="mtext_UNKNOWN">
ln</div> <div class="mo_UNKNOWN">
â€‰</div> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
(</div> <div class="mrow_UNKNOWN"> <div class="mn_UNKNOWN">
2</div> <div class="mo_UNKNOWN">
â‹…</div> <div class="mfrac_UNKNOWN"> <div class="mi_UNKNOWN">
x</div> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
â€‰</div> <div class="mtext_UNKNOWN">
ln</div> <div class="mo_UNKNOWN">
â€‰</div> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
(</div> <div class="mrow_UNKNOWN"> <div class="mn_UNKNOWN">
1</div> <div class="mo_UNKNOWN">
+</div> <div class="mn_UNKNOWN">
2</div> <div class="mo_UNKNOWN">
â‹…</div> <div class="mi_UNKNOWN">
x</div> </div> <div class="mo_UNKNOWN">
)</div> </div> </div> </div> </div> <div class="mo_UNKNOWN">
)</div> </div> </div> <div class="mo_UNKNOWN">
)</div> </div> </div></div></div> </div> where <div class="disp-formula" title="disp-formula"><span class="label" tagx="label" title="label">(3)</span><div class="alternatives" title="alternatives"> <div class="graphic" position="float" orientation="portrait" /><div class="math_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
x</div> <div class="mo_UNKNOWN">
=</div> <div class="mfrac_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="msub_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
[</div> <div class="mi_UNKNOWN">
S</div> <div class="mo_UNKNOWN">
]</div> </div> <div class="mn_UNKNOWN">
0</div> </div> </div> <div class="mrow_UNKNOWN"> <div class="msub_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
K</div> </div> <div class="mi_UNKNOWN">
m</div> </div> </div> </div> <div class="mo_UNKNOWN">
â‹…</div> <div class="mo_UNKNOWN">
â€‰</div> <div class="mtext_UNKNOWN">
exp</div> <div class="mo_UNKNOWN">
â€‰</div> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
(</div> <div class="mrow_UNKNOWN"> <div class="mfrac_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="msub_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
[</div> <div class="mi_UNKNOWN">
S</div> <div class="mo_UNKNOWN">
]</div> </div> <div class="mn_UNKNOWN">
0</div> </div> <div class="mo_UNKNOWN">
âˆ’</div> <div class="msub_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
V</div> </div> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
max</div> </div> </div> <div class="mo_UNKNOWN">
â‹…</div> <div class="mi_UNKNOWN">
t</div> </div> <div class="mrow_UNKNOWN"> <div class="msub_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
K</div> </div> <div class="mi_UNKNOWN">
m</div> </div> </div> </div> </div> <div class="mo_UNKNOWN">
)</div> </div> </div></div></div> </div> <p /> </div> </div> <div class="results" title="results"> <div class="title" tagx="title" title="title">
Results and discussion</div> <p>The individual timeâ€"course data for each sample (<a href="#F0001">Figure 1</a>), and the nonlinear regression analyses in terms of different computing approaches give the fitted theoretical curves for the Michaelisâ€"Menten reaction model. Progress curves were first analysed by numerical integration approach, which has been the most widely used method for timeâ€"course data analysis among enzymologists (<a href="#t0001">Table 1</a>, DynaFit numerical integration). Therefore, the best fit to the timeâ€"product concentration data obtained by performing DynaFit numerical integration programme yielded the reference values <i>K</i><sub>m</sub>, <i>V<sub>max</sub></i> and [<i>S</i>]<sub>0</sub> (see <a href="#t0001">Table 1</a>). However, the latter numerical approach can have drawbacks that are widely ignored and show several weak points<a href="#CIT0012"><sup>12</sup></a>, although the most common computing method to progressâ€"curve analysis these days is to use numerical integration solvers linked to nonlinear regression algorithms. Hence, we also estimated the kinetic parameters in terms of an algebraic approach that gives the direct solution of <a href="#M0001">Equation (1)</a> to the integrated Michaelisâ€"Menten rate equation (<a href="#t0001">Table 1</a>, DynaFit Lambert W)<a href="#CIT0009"><sup>9</sup></a>. Unfortunately, the requirement for the Lambert <i>W</i>(<i>x</i>) built-in function in software (e.g. Maplesoft Maple, Mathworks Matlab, BioKin DynaFit) in this alternative explicit expression to the integrated model rate equation for computing product accumulation with <a href="#M0001">Equation (1)</a> is another drawback as the most available curve-fitting software packages (e.g. Microsoft Excel, GraphPad Prism, Systat SigmaPlot) are not set up to handle equations that involve W(x), and hence they are of none use for direct timeâ€"course data analysis in terms of <a href="#M0001">Equation (1)</a>. To avoid this problem, we finally used the solution for [<i>P</i>]<i><sub>t</sub></i> based on an exact approximation <a href="#M0002">Equation (2)</a>, which is elementary and consequently easily implemented in any standard software<a href="#CIT0011"><sup>11</sup></a> and calculated kinetic parameters from progress curves (<a href="#t0001">Table 1</a>, GraphPad Lambert W). <a href="#F0001">Figure 1</a> shows a fit of the reaction progress curves data in GraphPad Prism by using <a href="#M0002">Equation (2)</a>; i.e. the approximation to the Lambert W function in <a href="#M0001">Equation (1)</a>. <a href="#t0001">Table 1</a> summarises all values of the fitted estimates of the kinetics parameters where the best parameter values yielded almost identical good fits to the experimental data for all of the computing methods. The given values are also in agreement with the results obtained by the traditional double-reciprocal Lineweaver-Burk plots methodology<a href="#CIT0002"><sup>2</sup></a>.</p> <div class="table-wrap_UNKNOWN" id="t0001" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 1.</span> <p>Parameters aquired by progressâ€"curve fitting. Comparison of fitted values obtained using the numerical integration approach (<i>DynaFit</i>, see Ref. [<a href="#CIT0009">9</a>]), the exact algebraic model <a href="#M0001">Equation (1)</a> with the Lambert W(x) function (<i>DynaFit</i>, see Ref. [<a href="#CIT0009">9</a>]), and the approximation of W(x) of the modified model <a href="#M0002">Equation (2)</a> (<i>GraphPad, Lambert W</i>, see Ref. [<a href="#CIT0011">11</a>]). The measurements for each sample were carried in duplicate or triplicate. Data are meansâ€‰Â±â€‰SD.</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup>  <thead> <tr> <th align="left">Â </th> <th align="center">DynaFit numerical integration</th> <th align="center">DynaFit Lambert W</th> <th align="center">GraphPad Lambert W</th> <th align="center">Â </th> <th align="center">DynaFit numerical integration</th> <th align="center">DynaFit Lambert W</th> <th align="center">GraphPad Lambert W</th> </tr> </thead> <tbody valign="top"> <tr> <td align="left">Â </td> <td colspan="3" align="center">Sample 1 <hr /> </td> <td align="left">Â </td> <td colspan="3" align="center">Sample 2 <hr /> </td> </tr> <tr> <td align="left">[S]<sub>0</sub> (Î¼M)</td> <td align="char" char="Â±"><i>101.0â€‰Â±â€‰0.1</i></td> <td align="char" char="Â±">101.0â€‰Â±â€‰0.1</td> <td align="char" char="Â±">100.9â€‰Â±â€‰0.1</td> <td align="left">[S]<sub>0</sub> (Î¼M)</td> <td align="char" char="Â±"><i>100.6â€‰Â±â€‰0.1</i></td> <td align="char" char="Â±">100.6â€‰Â±â€‰0.1</td> <td align="char" char="Â±">100.6â€‰Â±â€‰0.1</td> </tr> <tr> <td align="left">K<sub>m</sub> (Î¼M)</td> <td align="char" char="Â±"><i>11.3â€‰Â±â€‰0.5</i></td> <td align="char" char="Â±">11.3â€‰Â±â€‰0.5</td> <td align="char" char="Â±">11.0â€‰Â±â€‰0.5</td> <td align="left">K<sub>m</sub> (Î¼M)</td> <td align="char" char="Â±"><i>11.8â€‰Â±â€‰0.6</i></td> <td align="char" char="Â±">11.8â€‰Â±â€‰0.6</td> <td align="char" char="Â±">11.5â€‰Â±â€‰0.5</td> </tr> <tr> <td align="left"><i>V</i><sub>max</sub> (Î¼M/min)</td> <td align="left"><i>250.2â€‰Â±â€‰2.1</i><hr /> </td> <td align="left">222.3â€‰Â±â€‰8.6 <hr /> </td> <td align="char" char="Â±">248.8â€‰Â±â€‰1.8 <hr /> </td> <td align="left"><i>V</i><sub>max</sub> (Î¼M/min)</td> <td align="left"><i>241.3â€‰Â±â€‰2.3</i><hr /> </td> <td align="left">204.5â€‰Â±â€‰8.6 <hr /> </td> <td align="char" char="Â±">239.9â€‰Â±â€‰2.1 <hr /> </td> </tr> <tr> <td align="left">Â </td> <td colspan="3" align="center">Sample 3 <hr /> </td> <td align="left">Â </td> <td colspan="3" align="center">Sample 4 <hr /> </td> </tr> <tr> <td align="left">[S]<sub>0</sub> (Î¼M)</td> <td align="char" char="Â±"><i>98.3â€‰Â±â€‰0.2</i></td> <td align="char" char="Â±">98.3â€‰Â±â€‰0.2</td> <td align="char" char="Â±">98.3â€‰Â±â€‰0.1</td> <td align="left">[S]<sub>0</sub> (Î¼M)</td> <td align="char" char="Â±"><i>99.9â€‰Â±â€‰0.1</i></td> <td align="char" char="Â±">99.9â€‰Â±â€‰0.1</td> <td align="char" char="Â±">99.9â€‰Â±â€‰0.1</td> </tr> <tr> <td align="left">K<sub>m</sub> (Î¼M)</td> <td align="char" char="Â±"><i>8.6â€‰Â±â€‰0.5</i></td> <td align="char" char="Â±">8.6â€‰Â±â€‰0.5</td> <td align="char" char="Â±">8.4â€‰Â±â€‰0.4</td> <td align="left">K<sub>m</sub> (Î¼M)</td> <td align="char" char="Â±"><i>9.5â€‰Â±â€‰0.3</i></td> <td align="char" char="Â±">9.5â€‰Â±â€‰0.3</td> <td align="char" char="Â±">9.2â€‰Â±â€‰0.1</td> </tr> <tr> <td align="left"><i>V</i><sub>max</sub> (Î¼M/min)</td> <td align="left"><i>129.2â€‰Â±â€‰1.1</i><hr /> </td> <td align="left">150.5â€‰Â±â€‰7.4 <hr /> </td> <td align="char" char="Â±">128.6â€‰Â±â€‰1.0 <hr /> </td> <td align="left"><i>V</i><sub>max</sub> (Î¼M/min)</td> <td align="left"><i>204.3â€‰Â±â€‰1.1</i><hr /> </td> <td align="left">214.7â€‰Â±â€‰6.1 <hr /> </td> <td align="char" char="Â±">202.9â€‰Â±â€‰0.3 <hr /> </td> </tr> <tr> <td align="left">Â </td> <td colspan="3" align="center">Sample 5 <hr /> </td> <td align="left">Â </td> <td colspan="3" align="center">Sample 6 <hr /> </td> </tr> <tr> <td align="left">[S]<sub>0</sub> (Î¼M)</td> <td align="char" char="Â±"><i>99.2â€‰Â±â€‰0.2</i></td> <td align="char" char="Â±">97.6â€‰Â±â€‰0.1</td> <td align="char" char="Â±">99.2â€‰Â±â€‰0.2</td> <td align="left">[S]<sub>0</sub> (Î¼M)</td> <td align="char" char="Â±"><i>101.9â€‰Â±â€‰0.3</i></td> <td align="char" char="Â±">101.1â€‰Â±â€‰0.2</td> <td align="char" char="Â±">101.9â€‰Â±â€‰0.2</td> </tr> <tr> <td align="left">K<sub>m</sub> (Î¼M)</td> <td align="char" char="Â±"><i>13.8â€‰Â±â€‰1.2</i></td> <td align="char" char="Â±">11.4â€‰Â±â€‰0.6</td> <td align="char" char="Â±">13.5â€‰Â±â€‰1.1</td> <td align="left">K<sub>m</sub> (Î¼M)</td> <td align="char" char="Â±"><i>10.7â€‰Â±â€‰0.9</i></td> <td align="char" char="Â±">9.6â€‰Â±â€‰0.6</td> <td align="char" char="Â±">10.4â€‰Â±â€‰0.8</td> </tr> <tr> <td align="left"><i>V</i><sub>max</sub> (Î¼M/min)</td> <td align="char" char="Â±"><i>304.2â€‰Â±â€‰5.7</i></td> <td align="char" char="Â±">252â€‰Â±â€‰10</td> <td align="char" char="Â±">302.6â€‰Â±â€‰5.2</td> <td align="left"><i>V</i><sub>max</sub> (Î¼M/min)</td> <td align="char" char="Â±"><i>176.5â€‰Â±â€‰2.4</i></td> <td align="char" char="Â±">179.5â€‰Â±â€‰9.7</td> <td align="char" char="Â±">175.5â€‰Â±â€‰2.1</td> </tr> </tbody> </table> </div> <p>PON1 enzyme levels can range widely even between individuals with the same PON1 genotypes, and hence PON1 status which considers both PON1 genotypes and PON1 activity is a more informative for use in epidemiological studies then PON1 genotype alone<a href="#CIT0001"><sup>1</sup></a><sup>,</sup><a href="#CIT0003"><sup>3</sup></a>. Due to the relatively high concentrations of PON1 in human blood, many studies have also been performed on the inhibitory effect of medical drugs<a href="#CIT0013"><sup>13â€"16</sup></a> or metal elements<a href="#CIT0017"><sup>17</sup></a> on PON1 activity. Recent studies have shown that there is also a specific interaction of MPO-apoAI-PON1 on HDL surface that seems to be germane to the development of different diseases<a href="#CIT0008"><sup>8</sup></a>. Therefore, PON1 studies widely utilise various assays for determination of PON1 phenotypes whenever possible, but unfortunately they are usually limited only on the specific enzyme activity measurements, and mostly with highly toxic substrates<a href="#CIT0003"><sup>3â€"6</sup></a>.</p> <p>Although basic biochemical and physiological principles dictate that it is the activity of a given enzyme that is important with respect to its function, two kinetic parameters determine the activity of enzyme at given substrate concentration; i.e. limiting rate <i>V</i><sub>max</sub> (=<i>k</i><sub>cat</sub><i>Â·[E]<sub>T</sub></i>) which depends on turnover number and enzyme active sites concentration, and the Michaelis constant <i>K</i><sub>m</sub> which is not concentration dependent characteristics of an enzyme. However, the values of <i>K</i><sub>m</sub> are associated with polymorfic forms<a href="#CIT0002"><sup>2</sup></a>, enyzme modifications and its environment.</p> <p>Traditionally, the quantitative kinetics of enzyme-catalyzed reactions have been studied in terms of the correlation between initial rates and substrate concentrations according to the hyperbolic Michaelisâ€"Menten equation. Although direct analysis that use Michaelisâ€"Menten equation is easy to perform by various nonlinear regression curve-fitting programmes, the initial-velocity measurements still require a high number of individual experiments, due to the high sensitivity of the reaction rates to noise<a href="#CIT0018"><sup>18</sup></a>. On the other hand, analyses of complete progress curves can provide the same information, although this can be achieved with a single experimental assay that measures the kinetics data at every concentration between the initial value and that at the end of the reaction.</p> <p>However, the choice of the substrate is crucial for practical single progressâ€"curve assays. The required experimental condition for the independent estimation of both <i>K</i><sub>m</sub> and <i>V</i><sub>max</sub> from a progress curve is the initial substrate concentration which must be of the same order of magnitude as <i>K</i><sub>m</sub><a href="#CIT0012"><sup>12</sup></a><sub>,</sub> and the substrates with high <i>K</i><sub>m</sub> values are not usable for such assays. Consequently, we decided for measuring of the PON1 lactonase activity with dihydrocoumarine which is non-toxic and shows low but significant twofold difference of <i>K</i><sub>m</sub> values for the most widely PON1 isoforms (<i>K</i><sub>m</sub> = 22â€‰Î¼M for Q-type, <i>K</i><sub>m</sub> = 13â€‰Î¼M for R-type, see Ref. [<a href="#CIT0002">2</a>]) Consequently, we were also able to avoid the problems with insolubility and spontaneous hydrolysis with the use of low initial substrate concentration. It should be remembered that structuraly mimetic molecule 2-hydroxyquinoline (<a href="#F0002">Figure 2</a>) specifically inhibits enzymatic activities of PON1 with low <i>K</i><sub>i</sub> (âˆ¼2â€‰Î¼M)<a href="#CIT0002"><sup>2</sup></a>. However, since there evidently are two PON1 isoforms present, the assay yields an averaged <i>K</i><sub>m</sub> value in a case of heterozygote, meaning for correct PON1 status both, genotype and PON1 activity should be followed.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 2.</span></a></div>   <p>Paraoxonase-1 lactone substrate dihydrocoumarine (left) and its competitive inhibitor 2-hydroxyquinoline (right).</p>   </div> <p>In conclusion, traditional <i>K</i><sub>m</sub> determining double-reciprocal Lineweaver-Burk approach is not applicable when dealing with hundreds of biological samples in clinical diagnostic or high throughput screening drug research. This study provided an opportunity to carefully examine challenges that may exist when using quick and safe PON1 single progressâ€"curve measurements with non-toxic substrate, and simple direct calculation of kinetic parameters from raw timeâ€"concentration data by performing any available nonlinear curve-fitting approach and software like MS Excel<a href="#CIT0019"><sup>19</sup></a>. We believe that prompt and accurate evaluation of both kinetic parameters <i>K</i><sub>m</sub> and <i>V</i><sub>max</sub> is essential for determination of any enzyme status and provides more information than genotype and specific activity of the enzyme alone.</p> </div> </div> <div class="back" title="back"> <div class="ack" title="ack"> <div class="title" tagx="title" title="title">
Acknowledgements</div> <p>The authors thank Marjan KuÅ¾nik for his kind help with experimental work.</p> </div> <div class="COI-statement" title="COI-statement"> <div class="title" tagx="title" title="title">
Disclosure statement</div> <p>No potential conflict of interest was reported by the authors.</p> </div> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="CIT0001" /><span class="label" tagx="label" title="label">1</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Camps</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Marsillach</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Joven</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The paraoxonases: role in human diseases and methodological difficulties in measurements</span>. <span class="source" tagx="source" title="source">Crit Rev Clin Lab Sci</span><span class="year" tagx="year" title="year">2009</span>;<span class="volume" tagx="volume" title="volume">46</span>:<span class="fpage" tagx="fpage" title="fpage">83</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19255916">19255916</a></span></span></li> <li tag="ref"><a name="CIT0002" /><span class="label" tagx="label" title="label">2</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Billecke</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Draganov</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Counsell</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Human serum paraoxonase (PON1) isoenzyme Q and R hydrolyze lactones and cyclic carbonate esters</span>. <span class="source" tagx="source" title="source">Drug Metab Dispos</span><span class="year" tagx="year" title="year">2000</span>;<span class="volume" tagx="volume" title="volume">28</span>:<span class="fpage" tagx="fpage" title="fpage">1335</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11038162">11038162</a></span></span></li> <li tag="ref"><a name="CIT0003" /><span class="label" tagx="label" title="label">3</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ceron</span><span class="given-names" tagx="given-names" title="given-names">JJ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tecles</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tvarijonaviciute</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Serum paraoxonase-1 measurements: an update</span>. <span class="source" tagx="source" title="source">BMC Vet Res</span><span class="year" tagx="year" title="year">2014</span>;<span class="volume" tagx="volume" title="volume">10</span>:<span class="fpage" tagx="fpage" title="fpage">74</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24666514">24666514</a></span></span></li> <li tag="ref"><a name="CIT0004" /><span class="label" tagx="label" title="label">4</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Garelnabi</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Younis</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Paraoxonase-1 enzyme activity assay for clinical samples: validation and correlation studies</span>. <span class="source" tagx="source" title="source">Med Sci Monit</span><span class="year" tagx="year" title="year">2015</span>;<span class="volume" tagx="volume" title="volume">21</span>:<span class="fpage" tagx="fpage" title="fpage">902</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25814092">25814092</a></span></span></li> <li tag="ref"><a name="CIT0005" /><span class="label" tagx="label" title="label">5</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Teiber</span><span class="given-names" tagx="given-names" title="given-names">JF</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kramer</span><span class="given-names" tagx="given-names" title="given-names">GL</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Haley</span><span class="given-names" tagx="given-names" title="given-names">RW.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Methods for measuring serum activity levels of the 192 Q and R isoenzymes of paraoxonase 1 in QR heterozygous individuals</span>. <span class="source" tagx="source" title="source">Clin Chem</span><span class="year" tagx="year" title="year">2013</span>;<span class="volume" tagx="volume" title="volume">59</span>:<span class="fpage" tagx="fpage" title="fpage">1251</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23894162">23894162</a></span></span></li> <li tag="ref"><a name="CIT0006" /><span class="label" tagx="label" title="label">6</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mackness</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mackness</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Unexpectedly higher diazoxon hydrolysis by serum paraoxonase-1 in coronary heart disease</span>. <span class="source" tagx="source" title="source">Clin Biochem</span><span class="year" tagx="year" title="year">2019</span>;<span class="volume" tagx="volume" title="volume">65</span>:<span class="fpage" tagx="fpage" title="fpage">21</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30659791">30659791</a></span></span></li> <li tag="ref"><a name="CIT0007" /><span class="label" tagx="label" title="label">7</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Richter</span><span class="given-names" tagx="given-names" title="given-names">RJ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jarvik</span><span class="given-names" tagx="given-names" title="given-names">GP</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Furlong</span><span class="given-names" tagx="given-names" title="given-names">CE.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Determination of paraoxonase 1 status without the use of toxic organophosphate substrates</span>. <span class="source" tagx="source" title="source">Circ Cardiovasc Genet</span><span class="year" tagx="year" title="year">2008</span>;<span class="volume" tagx="volume" title="volume">1</span>:<span class="fpage" tagx="fpage" title="fpage">147</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20031556">20031556</a></span></span></li> <li tag="ref"><a name="CIT0008" /><span class="label" tagx="label" title="label">8</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Riwanto</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex</span>. <span class="source" tagx="source" title="source">J Clin Invest</span><span class="year" tagx="year" title="year">2013</span>;<span class="volume" tagx="volume" title="volume">123</span>:<span class="fpage" tagx="fpage" title="fpage">3815</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23908111">23908111</a></span></span></li> <li tag="ref"><a name="CIT0009" /><span class="label" tagx="label" title="label">9</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Reytor Gonzales</span><span class="given-names" tagx="given-names" title="given-names">ML</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cornell-Kennon</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shaefer</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">KuzmiÄ�</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span></span><span class="mixed-article-title" title="mixed-article-title">An algebraic model to determine substrate kinetic parameters by global nonlinear fit of progress curves</span>. <span class="source" tagx="source" title="source">Anal Biochem</span><span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">518</span>:<span class="fpage" tagx="fpage" title="fpage">16</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27823930">27823930</a></span></span></li> <li tag="ref"><a name="CIT0010" /><span class="label" tagx="label" title="label">10</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">GoliÄ�nik</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The integrated Michaelis-Menten rate equation: dÃ©jÃ vu or vu jÃ dÃ©?</span>. <span class="source" tagx="source" title="source">J Enzyme Inhib Chem Med</span><span class="year" tagx="year" title="year">2013</span>;<span class="volume" tagx="volume" title="volume">28</span>:<span class="fpage" tagx="fpage" title="fpage">879</span>.</span></li> <li tag="ref"><a name="CIT0011" /><span class="label" tagx="label" title="label">11</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">GoliÄ�nik</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">On the Lambert W function and its utility in biochemical kinetics</span>. <span class="source" tagx="source" title="source">Biochem Eng J</span><span class="year" tagx="year" title="year">2012</span>;<span class="volume" tagx="volume" title="volume">406</span>:<span class="fpage" tagx="fpage" title="fpage">94</span>.</span></li> <li tag="ref"><a name="CIT0012" /><span class="label" tagx="label" title="label">12</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zavrel</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kochanowski</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Spiess</span><span class="given-names" tagx="given-names" title="given-names">AC.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Comparison of different approaches and computer programs for progress curve analysis of enzyme kinetics</span>. <span class="source" tagx="source" title="source">Eng Life Sci</span><span class="year" tagx="year" title="year">2010</span>; <span class="volume" tagx="volume" title="volume">10</span>:<span class="fpage" tagx="fpage" title="fpage">191</span>.</span></li> <li tag="ref"><a name="CIT0013" /><span class="label" tagx="label" title="label">13</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Alici</span><span class="given-names" tagx="given-names" title="given-names">HA</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ekinci</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Beydemir</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Intravenous anesthetics inhibit human PON1 activity <i>inÂ vitro</i> and <i>inÂ vivo</i></span>. <span class="source" tagx="source" title="source">Clin Biochem</span><span class="year" tagx="year" title="year">2008</span>;<span class="volume" tagx="volume" title="volume">41</span>:<span class="fpage" tagx="fpage" title="fpage">1384</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18640108">18640108</a></span></span></li> <li tag="ref"><a name="CIT0014" /><span class="label" tagx="label" title="label">14</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ekinci</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Beydemir</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Evaluation of the impacts of antibiotic drugs on PON1</span>. <span class="source" tagx="source" title="source">Eur J Pharmacol</span><span class="year" tagx="year" title="year">2009</span>;<span class="volume" tagx="volume" title="volume">617</span>:<span class="fpage" tagx="fpage" title="fpage">84</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19577563">19577563</a></span></span></li> <li tag="ref"><a name="CIT0015" /><span class="label" tagx="label" title="label">15</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ekinci</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Beydemir</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Effect of some analgesics on paraoxonase-1 purified from human serum</span>. <span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span><span class="year" tagx="year" title="year">2009</span>;<span class="volume" tagx="volume" title="volume">24</span>:<span class="fpage" tagx="fpage" title="fpage">1034</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19548782">19548782</a></span></span></li> <li tag="ref"><a name="CIT0016" /><span class="label" tagx="label" title="label">16</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ekinci</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">ÅžentÃ¼rk</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Beydemir</span><span class="given-names" tagx="given-names" title="given-names">Åž</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">An alternative purification method for human serum paraoxonase 1 and its interactions with sulphonamides</span>. <span class="source" tagx="source" title="source">Chem Biol Drug. Des</span><span class="year" tagx="year" title="year">2010</span>;<span class="volume" tagx="volume" title="volume">76</span>:<span class="fpage" tagx="fpage" title="fpage">552</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21040495">21040495</a></span></span></li> <li tag="ref"><a name="CIT0017" /><span class="label" tagx="label" title="label">17</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ekinci</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Beydemir</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Purification of PON1 from human serum and assessment of enzyme kinetics against metal toxicity</span>. <span class="source" tagx="source" title="source">Biol Trace Elem Res</span><span class="year" tagx="year" title="year">2010</span>;<span class="volume" tagx="volume" title="volume">135</span>:<span class="fpage" tagx="fpage" title="fpage">112</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19727574">19727574</a></span></span></li> <li tag="ref"><a name="CIT0018" /><span class="label" tagx="label" title="label">18</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Duggleby</span><span class="given-names" tagx="given-names" title="given-names">RG.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Quantitative analysis of the time courses of enzyme-catalyzed reactions</span>. <span class="source" tagx="source" title="source">Methods</span><span class="year" tagx="year" title="year">2001</span>;<span class="volume" tagx="volume" title="volume">24</span>:<span class="fpage" tagx="fpage" title="fpage">168</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11384191">11384191</a></span></span></li> <li tag="ref"><a name="CIT0019" /><span class="label" tagx="label" title="label">19</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kemmer</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Keller</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Nonlinear least-squares data fitting in Excel spreadsheets</span>. <span class="source" tagx="source" title="source">Nature Protocols</span><span class="year" tagx="year" title="year">2010</span>;<span class="volume" tagx="volume" title="volume">5</span>:<span class="fpage" tagx="fpage" title="fpage">267</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20134427">20134427</a></span></span></li> </ul> </div> </div>  </body></html>